Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study

Stroke

Volumn 46, Issue 11, 2015, Pages 3131-3136

  Dearborn, Jennifer L ^a   Schneider, Andrea L C ^b,c   Sharrett, A Richey ^b   Mosley, Thomas H ^e   Bezerra, Daniel C ^f   Knopman, David S ^g   Selvin, Elizabeth ^b,d   Jack, Clifford R ^g   Coker, Laura H ^h   Alonso, Alvaro ⁱ   Wagenknecht, Lynne E ^h   Windham, Beverly G ^e   Gottesman, Rebecca F ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^f Pro Cardiaco Hospital   (Brazil)

^g MAYO CLINIC   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

atherosclerosis; body mass index; obesity; risk factors; white matter

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BODY MASS; CARDIOVASCULAR RISK; CENTRAL OBESITY; CEREBROVASCULAR DISEASE; DISEASE COURSE; FEMALE; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; WHITE MATTER HYPERINTENSITY; ATHEROSCLEROSIS; CLINICAL TRIAL; DEMOGRAPHY; INCIDENCE; MICROVASCULATURE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; STROKE, LACUNAR;

ATHEROSCLEROSIS; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MICROVESSELS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; STROKE, LACUNAR;

EID: 84945898587     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010060     Document Type: Article

References (30)

1. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM, Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 348 1215 1222. doi: 10.1056/NEJMoa022066
2. Eckel RH, Grundy SM, Zimmet PZ, The metabolic syndrome. Lancet 2005 365 1415 1428. doi: 10.1016/S0140-6736(05)66378-7
3. Dearborn JL, Knopman D, Sharrett AR, Schneider AL, Jack CR Jr, Coker LH, The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). Dement Geriatr Cogn Disord 2014 38 337 346. doi: 10.1159/000362265
4. Kassi E, Pervanidou P, Kaltsas G, Chrousos G, Metabolic syndrome: definitions and controversies. BMC Med 2011 9 48. doi: 10.1186/1741-7015-9-48
5. Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA, Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 2002 203-204 159 163
6. Brown WR, Moody DM, Thore CR, Anstrom JA, Challa VR, Microvascular changes in the white mater in dementia. J Neurol Sci 2009 283 28 31. doi: 10.1016/j.jns.2009.02.328
7. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993 43 1683 1689
8. Lammie GA, Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002 12 358 370
9. Fisher CM, Lacunes: small, deep cerebral infarcts. Neurology 1965 15 774 784
10. Bezerra DC, Sharrett AR, Matsushita K, Gottesman RF, Shibata D, Mosley TH Jr, Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology 2012 78 102 108. doi: 10.1212/WNL.0b013e31823efc42
11. The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989 129 687 702
12. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR, Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011 76 1879 1885. doi: 10.1212/WNL.0b013e31821d753f
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 1640 1645. doi: 10.1161/CIRCULATIONAHA.109.192644
14. Papp AC, Hatzakis H, Bracey A, Wu KK, ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989 61 15 19
15. Nägele U, Hägele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem 1984 22 165 174
16. Warnick GR, Benderson J, Albers JJ, Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982 28 1379 1388
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412 419
18. Mosley TH Jr, Knopman DS, Catellier DJ, Bryan N, Hutchinson RG, Grothues CA, Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005 64 2056 2062. doi: 10.1212/01.WNL.0000165985.97397.88
19. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996 27 2262 2270
20. Bryan RN, Manolio TA, Schertz LD, Jungreis C, Poirier VC, Elster AD, A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol 1994 15 1625 1633
21. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 1994 25 318 327
22. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001 14 668 676
23. Gottesman RF, Coresh J, Catellier DJ, Sharrett AR, Rose KM, Coker LH, Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010 41 3 8. doi: 10.1161/STROKEAHA.109.566992
24. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007 69 974 978. doi: 10.1212/01.wnl.0000266562.54684.bf
25. Bokura H, Yamaguchi S, Iijima K, Nagai A, Oguro H, Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008 39 1607 1609. doi: 10.1161/STROKEAHA.107.508630
26. Segura B, Jurado MA, Freixenet N, Falcón C, Junqué C, Arboix A, Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study. Neurology 2009 73 438 444. doi: 10.1212/WNL.0b013e3181b163cd
27. Ryu SY, Coutu J-P, Rosas HD, Salat D, The relationship between insulin resistance and white matter integrity in middle-aged and older adults. Alzheimer's and Dementia 2013 9 P108. doi: http://dx.doi.org/10.1016/j.jalz.2013.05.190
28. Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, LADIS Study Group Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008 39 1414 1420. doi: 10.1161/STROKEAHA.107.498535
29. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013 12 822 838. doi: 10.1016/S1474-4422(13)70124-8
30. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ, Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke 2002 33 26 30